|
US4911920A
(en)
|
1986-07-30 |
1990-03-27 |
Alcon Laboratories, Inc. |
Sustained release, comfort formulation for glaucoma therapy
|
|
FR2588189B1
(fr)
|
1985-10-03 |
1988-12-02 |
Merck Sharp & Dohme |
Composition pharmaceutique de type a transition de phase liquide-gel
|
|
DK0495421T3
(da)
|
1991-01-15 |
1996-12-09 |
Alcon Lab Inc |
Anvendelse af carragenaner i topiske ophthalmiske sammensætninger
|
|
US5212162A
(en)
|
1991-03-27 |
1993-05-18 |
Alcon Laboratories, Inc. |
Use of combinations gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions
|
|
DE19859684A1
(de)
|
1998-12-23 |
2000-06-29 |
Bayer Ag |
Verfahren zur Herstellung von Fluor enthaltenden Phenethylaminen sowie neue, Fluor enthalende beta-Iminovinyl- und beta-Iminoethylbenzole
|
|
US6982348B2
(en)
|
2001-01-26 |
2006-01-03 |
Takeda Pharmaceutical Company Limited |
Aminoethanol derivatives
|
|
JP2002293764A
(ja)
*
|
2001-01-26 |
2002-10-09 |
Takeda Chem Ind Ltd |
アミノエタノール誘導体
|
|
US7267121B2
(en)
|
2004-04-20 |
2007-09-11 |
Aerogen, Inc. |
Aerosol delivery apparatus and method for pressure-assisted breathing systems
|
|
HN2005000795A
(es)
|
2004-10-15 |
2010-08-19 |
Aventis Pharma Inc |
Pirimidinas como antagonistas del receptor de prostaglandina d2
|
|
WO2006079999A2
(en)
|
2006-04-09 |
2006-08-03 |
Barth Frederik H |
Induction of a novel state of mind with a 5-ht2a agonist and a nmda antagonist
|
|
WO2008016677A2
(en)
*
|
2006-08-02 |
2008-02-07 |
Auspex Pharmaceuticals, Inc. |
Preparation and utility of deuterated amphetamines
|
|
TWI415845B
(zh)
|
2006-10-03 |
2013-11-21 |
Arena Pharm Inc |
用於治療與5-ht2a血清素受體相關聯病症之作為5-ht2a血清素受體之調節劑的吡唑衍生物
|
|
CA2682432C
(en)
|
2007-03-30 |
2017-06-06 |
Duke University |
Device and method for delivery of a medicament
|
|
US20090318454A1
(en)
|
2008-03-24 |
2009-12-24 |
Weiner Carl P |
Novel antioxidants and methods of treatment
|
|
WO2016040822A1
(en)
|
2014-09-12 |
2016-03-17 |
Pinpoint Testing, Llc |
Ready-to-constitute analytical platforms for chemical analyses and quantification
|
|
CN107011313B
(zh)
|
2016-01-27 |
2021-11-30 |
天士力医药集团股份有限公司 |
取代桂皮酰胺衍生物在制备抗焦虑药物中的应用
|
|
US20190142851A1
(en)
|
2017-11-16 |
2019-05-16 |
CaaMTech, LLC |
Compositions comprising a psilocybin derivative and a cannabinoid
|
|
AR111808A1
(es)
|
2017-05-18 |
2019-08-21 |
Idorsia Pharmaceuticals Ltd |
Derivados de pirimidina como moduladores del receptor de pge2
|
|
US11723894B2
(en)
|
2017-10-26 |
2023-08-15 |
Terran Biosciences, Inc. |
Combination product for the treatment of neurological and/or psychiatric disorders
|
|
US12090145B2
(en)
|
2018-08-20 |
2024-09-17 |
Yale University |
Combination therapy for treating or preventing depression or other mood diseases
|
|
HUE066828T2
(hu)
|
2019-02-22 |
2024-09-28 |
Gh Res Ireland Limited |
5-Metoxi-N,N-Dimetiltriptamin (5-Meo-Dmt) súlyos depressziós rendellenesség kezelésére
|
|
US12616706B2
(en)
|
2019-03-07 |
2026-05-05 |
Arbormentis LLC |
Compositions and methods of use comprising substances with neural plasticity actions administered at non-psychedelic/psychotomimetic dosages and formulations
|
|
KR20220008824A
(ko)
|
2019-04-17 |
2022-01-21 |
컴퍼스 패쓰파인더 리미티드 |
실로시빈으로 불안 장애, 두통 장애 및 섭식 장애를 치료하는 방법
|
|
GB201907871D0
(en)
|
2019-06-03 |
2019-07-17 |
Small Pharma Ltd |
Therapeutic compositions
|
|
WO2021003467A1
(en)
|
2019-07-04 |
2021-01-07 |
Sw Holdings, Inc. |
Metered dosing compositions and methods of use of psychedelic compounds
|
|
CN112430187B
(zh)
|
2019-08-07 |
2023-01-17 |
北京奇点势能科技有限公司 |
一种α,β-氘代胺类化合物、氘代药物及其制备方法
|
|
US11246860B2
(en)
|
2019-11-07 |
2022-02-15 |
Lophora ApS |
5-HT2A agonists for use in treatment of depression
|
|
IL312785B2
(en)
|
2020-05-19 |
2026-06-01 |
Cybin Irl Ltd |
Deuterated tryptamine derivatives and methods of use
|
|
WO2021116503A2
(en)
|
2020-06-02 |
2021-06-17 |
Small Pharma Ltd |
Deuterated compounds
|
|
RU199823U1
(ru)
|
2020-06-10 |
2020-09-21 |
Общество С Ограниченной Ответственностью "Центр Передовых Радиационных Медицинских И Биологических Технологий |
Устройство для лечения бронхолегочных заболеваний
|
|
JP2023539113A
(ja)
|
2020-08-18 |
2023-09-13 |
サイビン アイアールエル リミテッド |
フェネチルアミン誘導体、組成物およびその使用方法
|
|
EP4221682A2
(en)
|
2020-10-02 |
2023-08-09 |
Cybin IRL Limited |
Methods for delivery of psychedelic medications by inhalation and systems for performing the methods
|
|
US20220267252A1
(en)
|
2021-02-24 |
2022-08-25 |
Mind Medicine, Inc. |
Mescaline derivatives with modified action
|
|
US20220323378A1
(en)
|
2021-04-03 |
2022-10-13 |
Shawn Joseph |
Pharmaceutical Compositions and Methods for Treating Mental Health Disorders and Promoting Neural Plasticity
|
|
WO2022221942A1
(en)
|
2021-04-19 |
2022-10-27 |
Betterlife Pharma Inc. |
Prevention of drug diversion
|
|
WO2022225884A1
(en)
|
2021-04-22 |
2022-10-27 |
Lennham Pharmaceuticals, Inc. |
Deuterated derivatives of psychedelic compounds and uses thereof
|
|
JP2024520832A
(ja)
|
2021-06-08 |
2024-05-24 |
エンセオジェニックス バイオサイエンシズ, インコーポレイテッド |
セロトニン受容体のジメトキシフェニルアルキルアミン活性化剤
|
|
US20240335401A1
(en)
|
2021-06-23 |
2024-10-10 |
Synaptive Therapeutics Llc |
Substituted phenethylamine for treating inflammation and psychological disorders
|
|
WO2023283386A2
(en)
|
2021-07-07 |
2023-01-12 |
Arcadia Medicine, Inc. |
Safer psychoactive compositions
|
|
AU2022311812A1
(en)
|
2021-07-14 |
2023-08-24 |
Altrartis Therapeutics Inc. |
Novel short-acting psychoactive compounds of the mdma class
|
|
EP4387952A1
(en)
|
2021-08-20 |
2024-06-26 |
Terran Biosciences Inc. |
Deuterated analogs and derivatives of 4-bromo-2,5-dimethoxyphenethylamine and uses thereof
|
|
AU2022342266B2
(en)
|
2021-09-08 |
2026-03-26 |
Cybin Irl Limited |
Combination drug therapies
|
|
US12465578B2
(en)
|
2021-09-25 |
2025-11-11 |
Alexander Shulgin Research Institute, Inc. |
Substituted alpha-ethyl phenylalkylamines
|
|
US20250236589A1
(en)
|
2022-02-15 |
2025-07-24 |
Cybin Irl Limited |
Therapeutic phenethylamine compositions and methods of use
|
|
AU2023222126A1
(en)
|
2022-02-15 |
2024-08-08 |
Cybin Irl Limited |
Phenethylamine derivatives, compositions, and methods of use
|
|
US20250205198A1
(en)
|
2022-03-31 |
2025-06-26 |
Cybin Irl Limited |
Methods for delivery of psychedelic medications by inhalation and systems for performing the methods
|
|
AU2023242469A1
(en)
|
2022-03-31 |
2024-09-05 |
Cybin Irl Limited |
Combination of nitrous oxide and 5-ht2a receptor agonists
|
|
JP2026513655A
(ja)
|
2022-10-28 |
2026-04-30 |
サイビン アイアールエル リミテッド |
フェネチルアミン化合物、組成物、及び使用方法
|